Johnson & Johnson

Johnson & Johnson (JNJ) Q4 2025 Earnings Call Transcript

Johnson & Johnson (JNJ) Q4 2025 Earnings Call Transcript

By
January 21, 2026
Johnson & Johnson (JNJ) Q3 2025 Earnings Call Transcript

Johnson & Johnson (JNJ) Q3 2025 Earnings Call Transcript

By
October 14, 2025
Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript

Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript

By
July 16, 2025
Johnson & Johnson (JNJ) Q1 2025 Earnings Call Transcript

Johnson & Johnson (JNJ) Q1 2025 Earnings Call Transcript

By
April 15, 2025
Johnson & Johnson (JNJ) Q4 2024 Earnings Call Transcript

Johnson & Johnson (JNJ) Q4 2024 Earnings Call Transcript

By
January 22, 2025
Johnson & Johnson exec Ashley McEvoy
Newsletters

A CEO contender left Johnson & Johnson. Was she penalized for saying she wanted to be a CEO?

By Emma Hinchliffe and Joey Abrams
December 7, 2023
J.M. Smucker’s CFO explains how sales of Uncrustables grew 22% in the latest quarter—and is on its way to being a $1 billion brand
Newsletters

J.M. Smucker’s CFO explains how sales of Uncrustables grew 22% in the latest quarter—and is on its way to being a $1 billion brand

By
December 7, 2023
His dad worked on the factory floor at Johnson & Johnson. Now he’s the CFO
Newsletters

His dad worked on the factory floor at Johnson & Johnson. Now he’s the CFO

By
December 6, 2023
13 inflation-proof stocks to buy for 2024
Finance

13 inflation-proof stocks to buy for 2024

By Will Daniel and Scott DeCarlo
November 28, 2023
Facing 50,000-plus lawsuits linking Baby Powder to cancer, Johnson & Johnson mulls a third bankruptcy filing 
Health

Facing 50,000-plus lawsuits linking Baby Powder to cancer, Johnson & Johnson mulls a third bankruptcy filing 

By Jef Feeley and Bloomberg
October 26, 2023
Generative AI is top of mind for all types of leaders, from Treasury Secretary Janet Yellen to J&J CEO Joaquin Duato
Leadership

Generative AI is top of mind for all types of leaders, from Treasury Secretary Janet Yellen to J&J CEO Joaquin Duato

By
October 11, 2023
JNJ CEO Joaquin Duato appears at Fortune's CEO Initiative conference.
Finance

J&J CEO Joaquin Duato discusses how he leads during challenging times and why the next decade will be the golden era for health innovation

By
October 3, 2023
Johnson & Johnson hit by 11,000 more lawsuits linking Baby Powder to cancer after judge throws $9 billion settlement case
Health

Johnson & Johnson hit by 11,000 more lawsuits linking Baby Powder to cancer after judge throws $9 billion settlement case

By Jef Feeley and Bloomberg
September 28, 2023
McKinsey agrees to pay $230m to settle suits claiming it fueled the opioid epidemic by advising drugmakers like Purdue how to sell painkillers
Health

McKinsey agrees to pay $230m to settle suits claiming it fueled the opioid epidemic by advising drugmakers like Purdue how to sell painkillers

By Joel Rosenblatt and Bloomberg
September 27, 2023
portrait of woman in suit jacket
Newsletters

This J&J exec sold Tylenol and Listerine. Now she runs its $27 billion medtech business

By Emma Hinchliffe and Joey Abrams
September 15, 2023

Most Popular